Comprehensive analysis of Native Hawaiians and other Pacific Islanders with early-onset colorectal cancer.
DOI:
10.1200/jco.2025.43.4_suppl.31
Publication Date:
2025-01-27T14:30:16Z
AUTHORS (2)
ABSTRACT
31
Background:
Rates of early-onset colorectal cancers (EOCRC) are increasing in Hawaii across all racial groups. Although previous studies have shown that Native Hawaiians have a higher mortality rate compared to other racial groups, the adjustment for sociodemographic factors have been limited. Our objective is to perform a comprehensive analysis of outcomes among patients with EOCRC in a racially diverse population accounting for tumor factors and patient sociodemographics.
Methods:
Patients diagnosed with EOCRC between 2000 and 2022 in Hawaii. Overall survival of Asians, Whites, and Native Hawaiian or Other Pacific Islanders (NHOPI) were calculated using the Kaplan-Meier method. Cox proportional hazard regression models assessed survival predictors adjusting for clinical and sociodemographic factors.
Results:
We included 379 patients in the final analysis. NHOPI had higher prevalence of underinsured status and higher histopathology grade compared to Whites and Asians. In unadjusted Cox regression, NHOPI race, underinsured status, grade, and stage were prognostic for survival. After adjusting for confounders, underinsured status, grade, and stage remained prognostic, but race was not significantly associated with survival.
Conclusions:
This study concludes that while NHOPI patients with EOCRC demonstrated poorer survival outcomes compared to other racial groups, this disparity was largely explained by the large percentage of underinsured NHOPI patients. Addressing treatment disparities in underinsured or uninsured is essential to improve survival outcomes.
Univariate and multivariate analysis of survival.
Univariate
Multivariate
HR (95% CI)
p-value
HR (95% CI)
p-value
Insurance
Private Insurance
-
-
-
-
Underinsured & Uninsured
1.865 (1.331-2.612)
<0.001
1.843 (1.285-2.643)
<0.001
Race
White
-
-
-
-
Asian
1.179 (0.746-1.865)
0.48
0.936 (0.585-1.496)
0.781
NHOPI
2.005 (1.231-3.265)
0.005
1.051 (0.714-1.547)
0.8
Age at diagnosis
0.996 (0.967-1.025)
0.771
1.002 (0.971-1.034)
0.901
Histopathology grade
Grade 1&2
-
-
-
-
Grade 3&4
2.785 (1.958-3.963)
<0.001
2.278 (1.571-3.303)
<0.001
Stage
Stage 1
-
-
-
-
Stage 2
1.104 (0.49-2.487)
0.81
1.028 (0.451-2.342)
0.948
Stage 3
3.255 (1.666-6.359)
<0.001
2.873 (1.447-5.706)
0.003
Stage 4
14.851 (7.499-29.41)
<0.001
12.778 (6.283-25.987)
<0.001
Unknown
3.738 (1.506-9.275)
0.004
3.008 (1.189-7.608)
0.02
Sex
Male
-
-
-
-
Female
0.812 (0.587-1.123)
0.22
0.852 (0.609-1.194)
0.352
Microsatellite status
Stable
-
-
Unstable
0.481 (0.148-1.562)
0.204
Not done/Unknown
1.08 (0.737-1.582)
0.739
Time to Treatment
Less than 1 month
-
-
-
-
More than 1 month
1.221 (0.863-1.727)
0.26
1.123 (0.784-1.609)
0.527
Location of Tumors
Right
-
-
-
-
Left
1.239 (0.76-2.02)
0.391
1.466 (0.886-2.425)
0.137
Rectal
1.391 (0.86-2.249)
0.178
1.211 (0.738-1.986)
0.449
NHOPI: Native Hawaiians and Other Pacific Islanders; HR: Hazard Ratio; CI: Confidence Interval.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....